Clinical reference Biomarker Directory
Back to directory

Glucose Phosphate Isomerase

Emerging

GPI deficiency is a rare glycolytic enzyme cause of hereditary hemolytic anemia, in the same family as pyruvate kinase deficiency.

Also known as GPI phosphoglucose isomerase
In plain language

This is one of several enzymes involved in how red blood cells make energy. A rare inherited shortage causes chronic anemia, in the same family of conditions as pyruvate kinase deficiency discussed earlier.

Biomarker & context

Glucose phosphate isomerase (GPI) is a glycolytic enzyme involved in red blood cell energy metabolism; its hereditary deficiency causes a rare form of non-spherocytic hemolytic anemia.

What it indicates

GPI deficiency impairs red blood cell energy production, leading to premature cell breakdown and chronic hemolytic anemia, following the same general pattern as the pyruvate kinase deficiency discussed earlier in this biomarker set.

Diagnosis & clinical testing

Diagnosed via red blood cell enzyme activity assay after excluding more common causes of hemolytic anemia; genetic testing of the GPI gene can confirm diagnosis.

Guiding treatment

Management is primarily supportive (transfusions as needed, folic acid supplementation, splenectomy in select severe cases), similar to management of other glycolytic enzyme deficiencies in this biomarker set, since no enzyme-specific therapy exists.

Clinical significance

Management is supportive, following the same general approach as other red cell enzyme deficiencies in this biomarker set.

References
  1. General hematology reference literature on glycolytic enzyme deficiencies causing hereditary non-spherocytic hemolytic anemia.